Actively Recruiting
Sleep Apnea in Patients With MGUS and MM
Led by Michael Tomasson · Updated on 2025-11-10
200
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
Sponsors
M
Michael Tomasson
Lead Sponsor
D
Department of Health and Human Services
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
CONDITIONS
Official Title
Sleep Apnea in Patients With MGUS and MM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with MGUS or MM
- Scheduled to receive a bone marrow biopsy as part of standard medical care
- Able to provide bone marrow specimens during this procedure
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
M
Michael Tomasson, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here